Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q19903309> ?p ?o }
Showing triples 1 to 26 of
26
with 100 triples per page.
- Q19903309 subject Q6155998.
- Q19903309 subject Q7189906.
- Q19903309 subject Q7211399.
- Q19903309 subject Q8774015.
- Q19903309 abstract "Anthrax immune globulin, tradename Anthrasil, is a human immune globulin that is used in combination with antibiotics to treat anthrax. It was developed by Cangene and purchased in 2011 by the Biomedical Advanced Research and Development Authority (BARDA) under Project Bioshield. On 24 March 2015 it was granted approval by the United States Food and Drug Administration for use in treating inhalation anthrax in conjunction with antibiotics.".
- Q19903309 wikiPageWikiLink Q12187.
- Q19903309 wikiPageWikiLink Q129104.
- Q19903309 wikiPageWikiLink Q204711.
- Q19903309 wikiPageWikiLink Q4915100.
- Q19903309 wikiPageWikiLink Q5032343.
- Q19903309 wikiPageWikiLink Q53467.
- Q19903309 wikiPageWikiLink Q547283.
- Q19903309 wikiPageWikiLink Q6155998.
- Q19903309 wikiPageWikiLink Q7189906.
- Q19903309 wikiPageWikiLink Q7211399.
- Q19903309 wikiPageWikiLink Q7249008.
- Q19903309 wikiPageWikiLink Q79460.
- Q19903309 wikiPageWikiLink Q79749.
- Q19903309 wikiPageWikiLink Q8774015.
- Q19903309 type ChemicalSubstance.
- Q19903309 type Drug.
- Q19903309 type ChemicalObject.
- Q19903309 type Thing.
- Q19903309 type Q8386.
- Q19903309 comment "Anthrax immune globulin, tradename Anthrasil, is a human immune globulin that is used in combination with antibiotics to treat anthrax. It was developed by Cangene and purchased in 2011 by the Biomedical Advanced Research and Development Authority (BARDA) under Project Bioshield. On 24 March 2015 it was granted approval by the United States Food and Drug Administration for use in treating inhalation anthrax in conjunction with antibiotics.".
- Q19903309 label "Anthrax immune globulin".